Coldstream Capital Management Inc. Has $670,000 Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Coldstream Capital Management Inc. boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 28.2% in the second quarter, HoldingsChannel.com reports. The firm owned 8,599 shares of the company’s stock after buying an additional 1,890 shares during the period. Coldstream Capital Management Inc.’s holdings in GE HealthCare Technologies were worth $670,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of GEHC. Vanguard Group Inc. increased its stake in shares of GE HealthCare Technologies by 9.2% in the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after buying an additional 4,107,746 shares during the period. Norges Bank acquired a new stake in GE HealthCare Technologies during the 4th quarter valued at approximately $229,052,000. Capital Research Global Investors raised its holdings in GE HealthCare Technologies by 5.2% during the 1st quarter. Capital Research Global Investors now owns 53,991,923 shares of the company’s stock worth $4,908,406,000 after purchasing an additional 2,647,204 shares during the last quarter. Perpetual Ltd acquired a new position in shares of GE HealthCare Technologies in the 1st quarter worth approximately $96,135,000. Finally, Jacobs Levy Equity Management Inc. boosted its stake in shares of GE HealthCare Technologies by 4,959.8% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 758,514 shares of the company’s stock valued at $68,957,000 after purchasing an additional 743,523 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Trading Up 0.3 %

NASDAQ GEHC opened at $87.46 on Friday. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The business has a 50 day moving average price of $82.85 and a 200-day moving average price of $83.50. The company has a market cap of $39.92 billion, a price-to-earnings ratio of 25.57, a P/E/G ratio of 3.18 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The business had revenue of $4.84 billion during the quarter, compared to analyst estimates of $4.88 billion. During the same quarter in the previous year, the business posted $0.92 EPS. GE HealthCare Technologies’s quarterly revenue was up .5% on a year-over-year basis. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were paid a dividend of $0.03 per share. The ex-dividend date of this dividend was Friday, July 19th. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.51%.

Insiders Place Their Bets

In other news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the transaction, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.27% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently weighed in on GEHC. Stifel Nicolaus assumed coverage on shares of GE HealthCare Technologies in a research note on Tuesday, August 6th. They set a “buy” rating and a $100.00 target price for the company. JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a research report on Monday. They issued a “neutral” rating and a $90.00 price objective for the company. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Finally, The Goldman Sachs Group assumed coverage on GE HealthCare Technologies in a report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price for the company. Six investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $94.58.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.